GMRE (GMRE)

Global Medical REIT Inc. (NYSE:XRN) has received an average "Hold" rating from eight analysts, with a consensus 12-month price target of $40.25. Insiders have recently purchased over $373,000 worth of shares, and institutional investors hold 57.52% of the company. The REIT also announced a monthly dividend of $0.16 per share, yielding 5.2%.

Zacks Research has upgraded Global Medical REIT (NYSE:XRN) to a "hold" rating, contributing to a generally neutral outlook from analysts, with an average target price of $40.25. The company's stock opened at $37.31, has a market cap of approximately $493.8 million, and shows significant insider buying and institutional ownership. Recent insider transactions include key executives and directors purchasing shares, alongside various institutional investors increasing their stakes.

BMO Capital Markets has increased its price target for Global Medical REIT (NYSE:XRN) from $39.00 to $40.00, maintaining a "market perform" rating. This new target suggests a potential upside of 10.19% from the stock's current price. Despite mixed analyst sentiment, the consensus rating for XRN remains a "Moderate Buy" with an average price target of $40.25, and recent insider buying by executives indicates confidence in the company.

Global Medical REIT Inc. (NYSE:XRN) has an average analyst rating of "Hold" with a consensus 12-month target price of $40.00. While some firms downgraded their ratings, Citizens JMP raised its target to $42.00, maintaining an "outperform" rating. The company recently announced a monthly dividend of $0.16 per share, yielding 5.1%, and has seen insider buying from its director and COO.

This article provides an "Institutional Confidence" score for Global Medical REIT Inc (GMRE) as of February 20, 2026, which is 7.00 with no change from the previous score. It lists major institutional shareholders and their shareholdings, including BlackRock, Zensun Enterprises, Heartland Advisors, Alyeska Investment Group, Mirae Asset Global Investments, State Street Investment Management, Geode Capital Management, and Invesco Capital Management. These details offer insight into the institutional investment activity surrounding GMRE.